About Clinica Santa Maria
Clinical Trials at Clinica Santa Maria
During the past decade, Clinica Santa Maria conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on
average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Clinica Santa Maria" #1 sponsor was "Clinica Santa Maria" with 2 trials, followed by "Telik" with 2 trials
sponsored, "Terumo Europe N.V." with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc."
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica Santa Maria"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Clinica Santa Maria
According to Clinical.Site data, the most researched conditions in "Clinica Santa Maria" are
"Carcinoma, Non-Small-Cell Lung" (2 trials), "Coronary Artery Disease" (2 trials), "Arterial Thrombosis" (1 trials), "Arthritis, Rheumatoid" (1 trials) and "First Line Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Clinica Santa Maria" in a lesser frequency.
Clinical Trials Intervention Types at Clinica Santa Maria
Most popular intervention types in "Clinica Santa Maria" are "Drug" (11 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Placebo" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody" (1 trials) and "Atropine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinica Santa Maria
The vast majority of trials in "Clinica Santa Maria" are
11 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Clinica Santa Maria
Currently, there are NaN active trials in "Clinica Santa Maria".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Clinica Santa Maria,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Clinica Santa Maria, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Clinica Santa Maria
Clinica Santa Maria has several departments that took part in Clinical trials: "Clínica Santa María, Sección Reumatología" - 2 trials